Brookline analyst Kemp Dolliver downgraded Eyenovia (EYEN) to Hold from Buy without a price target following the CHAPERONE study failure.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio